Fact Based List:
Top Five Prescription Drugs by Revenue in 2016
Submitted by Clive Riddle on Mon, 03/20/2017 - 17:20
- Humira (AbbVie) $16.078 billion
- Harvoni (Gilead Sciences) $9.081 billion
- Enbrel (Amgen and Pfizer) $8.874 bllion
- Rituxan (Roche [Genentech] and Biogen) $8.583 billion
- Remicade (Johnson & Johnson and Merck) $7.829 billion
Source: Genetic Engineering & Biotechnology News
Source URL: http://www.genengnews.com/the-lists/the-top-15-best-selling-...
List Ratings: |
Lists You Might Also Be Interested In
- CMS: Top 10 Highest Prescribing Specialties Under Medicare by total cost of prescriptions
- Pediatrics study: Percentages of teens and young adults who received opioid prescriptions, 2005 to 2015
- New regulations for Medicare Advantage and the Part D prescription drug benefit
- Employers and prescription benefit deductibles
- The Six Key Stakeholders in the Prescription Drug Distribution Chain
Login or register to post comments